Monday, September 21, 2020

Orthopedic Surgeon Explains Michael Thomas’ High Ankle Sprain

Michael Thomas picked up an injury in the Sunday’s game, with NFL stating he has a high ankle sprain. Orthopedic surgeon Dr. Tim Finney has explained Thomas’ high ankle sprain, although he is not Thomas’ treating doctor. He said Thomas can undergo a surgery called TightRope.

Generic Cholesterol-Lowering Drugs Saved Medicare Billions of Dollars, Finds Report

A new report has found that switching to generic cholesterol-lowering drugs from branded ones has saved Medicare billions of dollars from 2014 to 2018. Cholesterol-lowering drugs are often prescribed to reduce LD-cholesterol and total cholesterol in order to prevent stroke or heart attack.

More Than 25% Asthma Patients Are Given Potentially Dangerous Amounts of Steroids

A new study has shown that more than 25% of asthmatic patients in Australia are given potentially dangerous steroid tablets, which could make them vulnerable to serious side effects, including diabetes, cataracts, and osteoporosis. The study said the best way to treat asthma is by using preventive inhalers rather than steroids.

Sildenafil and Milrinone Improved Prognosis in Newborns with Persistent Pulmonary Hypertension

A new study has found that a combination of sildenafil (Revatio) and milrinone (Primacor) has proven effective in newborns with severe persistent pulmonary hypertension (PPHN). The study found that the combination of sildenafil and milrinone improved pulmonary artery systolic pressure and oxygen level.

AstraZeneca COVID-19 Vaccine Trial Participant Not Officially Diagnosed With Rare Neurological Condition

AstraZeneca has said in a statement that a sick participant, which halted their Phase III trials of their coronavirus vaccine candidate, has not officially been diagnosed with transverse myelitis, a rare neurological condition characterized by the inflammation of the spinal cord.

FDA Approves Kesimpta for the Treatment of Relapsing Forms of Multiple Sclerosis

The Food and Drug Administration (FDA) has approved the use of ofatumumab (Kesimpta), developed by Novartis, in adult patients with relapsing forms of multiple sclerosis (MS). The drug was initially approved in 2009 for the treatment of chronic lymphocytic leukemia.

Adding Sildenafil to Pirfenidone Found Ineffective In Patients with Advanced Idiopathic Pulmonary Fibrosis

A new trial has found that adding sildenafil to pirfenidone did not provide a clinical benefit in patients with advanced idiopathic pulmonary fibrosis (IPF) and the risk of pulmonary arterial hypertension. The study researchers interpreted that adding sildenafil to pirfenidone was not effective for IPF patients.